Invesco’s Centessa Pharmaceuticals CNTA Stock Holding History

Invesco’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,034	Closed	-$279K	–	3842
2026 Q1	$279K	Buy	+7,034	New	+$180K	﹤0.01%	3374

Invesco's CNTA Position: Q2 2026 in Review

Invesco sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 7,034 shares — an estimated $279K sold.

Invesco first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $279K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Invesco reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Invesco sold 7,034 Centessa Pharmaceuticals shares in Q2 2026, an estimated $279K.
Invesco first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Invesco's Centessa Pharmaceuticals position peaked at $279K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.